| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |